Complex cytogenetic findings in the bone marrow of a chronic idiopathic myelofibrosis patient

Complex cytogenetic findings in the bone marrow of a chronic idiopathic myelofibrosis patient

Show other versions (1)

Chronic idiopathic myelofibrosis is a myeloproliferative disorder characterized by splenomegaly, myeloid metaplasia and reactive bone marrow fibrosis. Karyotype analysis of the bone marrow is an integral part of the diagnosis, especially as a discriminative tool in ruling out reactive conditions. Th...

Full description

Bibliographic Details
Main Authors:	Tuğçe Bulakbaşı Balcı, Meltem Yüksel, Zerrin Yılmaz, Feride İffet Şahin
Format:	Article
Language:	English
Published:	Galenos Publishing House 2010-06-01
Series:	Turkish Journal of Hematology
Subjects:	chronic idiopathic myelofibrosis cytogenetics
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-33043

Similar Items

Complex cytogenetic findings in the bone marrow of a chronic idiopathic myelofibrosis patient
by: Tuğçe Bulakbaşı Balcı, et al.
Published: (2010-06-01)

Idiopathic myelofibrosis mimicking hemolytic anemia
by: R Baral, et al.
Published: (2012-09-01)

Significance of cytogenetic-risk categories and refined international prognostic scoring system for overall survival in primary myelofibrosis: A single-center experience
by: Đorđević Vesna, et al.
Published: (2020-01-01)

Acute massive myelofibrosis with acutelymphoblastic leukemia
by: Namık Özbek, et al.
Published: (2009-12-01)

Primary myelofibrosis L.
by: L. M. Meshcheryakova, et al.
Published: (2014-07-01)

Primary myelofibrosis L.
by: L. M. Meshcheryakova, et al.
Published: (2014-07-01)

Extramedullary hematopoiesis in an inguinal lymph node: an unusual presentation of primary myelofibrosis
by: Nausheen Yaqoob, et al.
Published: (2022-06-01)

Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data
by: Wang N, et al.
Published: (2020-07-01)

Pulmonary hypertension diagnosed by echocardiography during idiopathic myelofibrosis. A case report and a brief review of the literature
by: Perrone Claudio, et al.
Published: (2010-08-01)

Combination of multiple myeloma and chronic idiopathic myelofibrosis: a case report
by: N. A. Romanenko, et al.
Published: (2022-11-01)

Fluorescence in situ hybridization analysis of the hTERC region in acute myeloid leukemia patients
by: Özge Özer, et al.
Published: (2011-06-01)

Fluorescence in situ hybridization analysis of the hTERC region in acute myeloid leukemia patients
by: Özge Özer, et al.
Published: (2011-05-01)

Bone marrow fibrosis (pseudo-myelofibrosis) in human kala-azar
by: Rocha Filho Francisco Dário, et al.
Published: (2000-01-01)

Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping
by: Álvaro Díaz-González, et al.
Published: (2023-06-01)

Use of ropeginterferon in inducing graft versus myelofibrosis effect in post‐transplant myelofibrosis relapse
by: Barnali Srivastava, et al.
Published: (2023-09-01)

Myelofibrosis: An unusual presentation of disseminated tuberculosis
by: Neha Sharma, et al.
Published: (2020-01-01)

JAK2 V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia
by: Bárbara da Costa Reis Monte-Mór, et al.
Published: (2007-03-01)

Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
by: Hans Michael Kvasnicka, et al.
Published: (2018-03-01)

Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report
by: Meltem Aylı, et al.
Published: (2015-05-01)

Tratamiento de la mielofibrosis idiopática crónica con bajas dosis de talidomida.: Comunicación de 2 casos Treatment of chronic idiopathic myelofibrosis with talidomide low doses.: Report of 2 cases
by: Onel M. Ávila Cabrera, et al.
Published: (2010-08-01)

Possibilities of targeted therapy for myelofibrosis: Moscow experience
by: O. Yu. Vinogradova, et al.
Published: (2022-11-01)

The Genetic Basis of Primary Myelofibrosis and Its Clinical Relevance
by: Elisa Rumi, et al.
Published: (2020-11-01)

Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality
by: Shinya Rai, et al.
Published: (2019-01-01)

Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity
by: Fabiola Guerra, et al.
Published: (2022-11-01)

Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis
by: Maria Zingariello, et al.
Published: (2020-11-01)

Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis
by: María García-Fortes, et al.
Published: (2022-05-01)

Long-term results of splenectomy in primary myelofibrosis
by: L. M. Meshcheryakova, et al.
Published: (2014-07-01)

Long-term results of splenectomy in primary myelofibrosis
by: L. M. Meshcheryakova, et al.
Published: (2014-07-01)

Mutation profile in Indian primary myelofibrosis patients and its clinical implications
by: Vinod R Patil, et al.
Published: (2019-01-01)

Benign Parathyroid Adenoma Presenting with Unusual Parathyroid Crisis, Anemia and Myelofibrosis
by: Shu-Chuan Huang, et al.
Published: (2007-01-01)

Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression
by: Joseph Tripodi, et al.
Published: (2024-04-01)

Blastoid Variant Mantle Cell Lymphoma with Complex Karyotype Including 11q Duplication
by: Özge Özer, et al.
Published: (2014-08-01)

Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis
by: Andrew T. Kuykendall, et al.
Published: (2020-08-01)

Assessment of Bone Marrow Biopsy and Cytogenetic Findings in Patients with Multiple Myeloma
by: Ahmet Seyhanlı, et al.
Published: (2022-05-01)

SPECTRUM OF AFFECTED GENES IN UKRAINIAN PATIENTS WITH PRIMARY MYELOFIBROSIS
by: Poluben L., et al.
Published: (2018-12-01)

Morphological and Immunophenotypical Changes of Human Bone Marrow Adipocytes in Marrow Metastasis and Myelofibrosis
by: Michele Dello Spedale Venti, et al.
Published: (2022-06-01)

Autoinflammation and Myelofibrosis: Report of a Case
by: Prasad Koduri, et al.
Published: (2023-08-01)

Flow cytogenetics/
by: Gray, Joe W.
Published: (1989)

Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis
by: Stephen T. Oh, et al.
Published: (2024-02-01)

Primary autoimmune myelofibrosis: A case report in a child
by: Zufit Hexner‐Erlichman, et al.
Published: (2020-07-01)